Others

Kilitch Drugs (India) Ltd. - Outcome of Board Meeting

| Updated on August 31, 2018 Published on August 31, 2018

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that the Board of Directors of the company, at its meeting held today, i.e. August 31, 2018 have considered and approved the allotment of 16,00,000 Equity shares of the company of face value of Rs. 10/- each at a price of Rs. 59/- per share (including a premium of Rs. 49/- per share) upon conversion of 16,00,000 Warrants issued on preferential basis to the Promoters of the company. Consequent to such conversion, the paid up capital of the company shall increase from existing Rs. 13,75,52,420/- divided into 13755242 Equity Shares of Rs. 10/- each to Rs. 15,35,52,420/-divided into 15355242 Equity Shares of Rs. 10/- each.

Pdf Link: Kilitch Drugs (India) Ltd. - Outcome of Board Meeting

Source : BSE - www.bseindia.com

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on August 31, 2018
This article is closed for comments.
Please Email the Editor